STOCKHOLDERS' EQUITY (Tables)
|
3 Months Ended |
Apr. 30, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock-based Compensation Expense |
The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | Three Months Ended April 30, | | | | 2026 | | 2025 | | | | | Cost of revenue | $ | 5,895 | | | $ | 4,665 | | | | | | Research and development | 28,948 | | | 20,941 | | | | | | Sales and marketing | 20,285 | | | 22,915 | | | | | | General and administrative | 19,761 | | | 20,170 | | | | | | Restructuring | — | | | (36) | | | | | | Total | $ | 74,889 | | | $ | 68,655 | | | | | |
|
| Schedule of Restricted Stock Units |
A summary of our RSU activity is as follows:
| | | | | | | | | | | | | Number of RSUs | | Weighted-Average Grant Date Fair Value | Outstanding as of January 31, 2026 | 31,653,685 | | | $ | 18.99 | | Granted | 22,154,882 | | | 13.35 | | | Released | (3,012,489) | | | 20.32 | | | Forfeited | (1,285,814) | | | 19.23 | | Outstanding as of April 30, 2026 | 49,510,264 | | | $ | 16.38 | |
|
| Schedule of Performance Stock Units |
A summary of our PSU activity is as follows: | | | | | | | | | | | | | Number of PSUs | | Weighted-Average Grant Date Fair Value | Outstanding as of January 31, 2026 | 1,246,801 | | | $ | 17.06 | | | Granted | — | | | — | | | Released | (477,776) | | | 17.39 | | Forfeited | (81,521) | | | 17.26 | | Outstanding as of April 30, 2026 | 687,504 | | | $ | 16.81 | |
|
| Schedule of Stock Options |
A summary of our stock option activity is as follows:
| | | | | | | | | | | | | | | | | Number of Options | | Weighted-Average Exercise Price | | | | | Outstanding as of January 31, 2026 | 9,443,196 | | | $ | 6.92 | | | | | | | | | | | | | | | Exercised | (216,140) | | | 4.08 | | | | | | | Forfeited | (11,447) | | | 2.03 | | | | | | Outstanding as of April 30, 2026 | 9,215,609 | | | $ | 6.99 | | | | | | Vested and expected to vest as of April 30, 2026 | 9,215,609 | | | $ | 6.99 | | | | | | Vested and exercisable as of April 30, 2026 | 7,596,812 | | | $ | 6.77 | | | | | |
|
| Schedule of Restricted Common Stock |
Restricted common stock is included in issued and outstanding shares as they are legally issued and outstanding but are not deemed outstanding for accounting purposes until the shares vest. A summary of our restricted common stock activity is as follows:
| | | | | | | | | | | | | Number of Shares | | Weighted-Average Grant Date Fair Value | Outstanding as of January 31, 2026 | 3,484,135 | | | $ | 20.60 | | | Granted | — | | | — | | Vested | (372,906) | | | 21.97 | | Unvested balance as of April 30, 2026 | 3,111,229 | | | $ | 20.43 | |
|